Exploring methandienone metabolites generated via homogenized camel liver: Advancements for anti‐doping applications through High Resolution‐Liquid Chromatography Mass Spectrometry analysis
Rapid Communications in Mass Spectrometry · 2024
DOI: 10.1002/rcm.9902 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rapid Communications in Mass Spectrometry, 2024. Verfasst von Ramees Abdulla Vazhat und 3 weiteren Autor:innen. Beteiligte Einrichtung: Camel Forensic Laboratory, Central Veterinary Research Laboratory, Dubai, 597, United Arab Emirates. Hauptthemen laut MEDLINE: Camelus, Doping in Sports, Substance Abuse Detection, Liver. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
Rationale
Anabolic steroids, also known as anabolic–androgenic steroids (AAS), encompass steroidal androgens such as testosterone, as well as synthetic counterparts with similar structures and effects. The misuse of AAS has increased over the years, leading to ethical and welfare concerns in sports. The World Anti‐Doping Agency (WADA) and the International Federation for Equestrian Sports (FEI) have banned AAS in relevant sports. Methandienone is one of the most identified anabolic androgenic steroids in sports drug testing, Therefore, reliable detection methods are crucial for effective doping control and maintaining the integrity of the sports.
Methods
This study explores the use of homogenized camel liver for detecting methandienone metabolites in camels. The biotransformation pathways of methandienone in homogenized camel liver tissues are analyzed using Liquid Chromatography‐High Resolution Mass Spectrometry (LC‐HRMS) to identify and characterize the phase I and phase II metabolites. Chromatographic separation was achieved using a Thermo‐Hypersil C18 column.
Results
The study has identified 11 methandienone metabolites (M1–M11), this includes 10 phase I and one phase II metabolite. A glucuronic acid conjugate of methandienone was observed in this study, but no sulfonic acid conjugations were found. The metabolites and their possible chemical structures, along with their fragmentation patterns are confirmed using MSMS (MS2) experiments in data‐independent acquisition (DIA) mode.
Conclusions
These findings serve as a vital tool for the rapid detection of methandienone, combating its illicit use in camel racing. Comprehensive screenings covering both the parent drug and its metabolites are recommended to improve detection accuracy and ensure regulatory compliance in sports doping. Future research should explore methandienone's metabolite profile in administered camel samples.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Camel Forensic Laboratory, Central Veterinary Research Laboratory, Dubai, 597, United Arab Emirates.
- Postgraduate and Research Department of Chemistry, Khadir Mohideen College, Affiliated to Bharathidasan University, Adirampattinam, 614701, India.
ORCID-Profile: Ramees Abdulla Vazhat, N A Mohamed Farook, Jahfar Nalakath, Praseen Ondern Komathu
Zitieren
APA
Vazhat, R. A., Farook, N. A. M., Nalakath, J., & Komathu, P. O. (2024). Exploring methandienone metabolites generated via homogenized camel liver: Advancements for anti‐doping applications through High Resolution‐Liquid Chromatography Mass Spectrometry analysis. Rapid Communications in Mass Spectrometry. https://doi.org/10.1002/rcm.9902
Vancouver
Vazhat RA, Farook NAM, Nalakath J, Komathu PO. Exploring methandienone metabolites generated via homogenized camel liver: Advancements for anti‐doping applications through High Resolution‐Liquid Chromatography Mass Spectrometry analysis. Rapid Communications in Mass Spectrometry. 2024. doi:10.1002/rcm.9902
BibTeX
@article{Vazhat2024,
author = {Vazhat, Ramees Abdulla and Farook, N A Mohamed and Nalakath, Jahfar and Komathu, Praseen Ondern},
title = {Exploring methandienone metabolites generated via homogenized camel liver: Advancements for anti‐doping applications through High Resolution‐Liquid Chromatography Mass Spectrometry analysis},
journal = {Rapid Communications in Mass Spectrometry},
year = {2024},
doi = {10.1002/rcm.9902}
}
EUVIMED